(0.05%) 5 471.78 points
(0.08%) 39 142 points
(0.35%) 17 779 points
(-0.07%) $80.77
(-3.66%) $2.66
(-0.77%) $2 312.90
(0.25%) $28.94
(3.59%) $1 021.80
(0.29%) $0.936
(0.68%) $10.68
(0.45%) $0.792
(-0.28%) $87.25
Live Chart Being Loaded With Signals
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test...
Stats | |
---|---|
今日成交量 | 4 439 |
平均成交量 | 0 |
市值 | 12.31M |
EPS | $-0.200 ( Q1 | 2024-05-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-18 | Burton Paul Frederick | Buy | 0 | |
2023-12-31 | Levy Oded | Buy | 5 020 | Common Stock |
2023-12-31 | Levy Oded | Sell | 0 | Restricted Stock Units |
2023-12-31 | Sim Brandon | Buy | 5 020 | Common Stock |
2023-12-31 | Sim Brandon | Sell | 0 | Restricted Stock Units |
INSIDER POWER |
---|
100.00 |
Last 61 transactions |
Buy: 2 578 621 | Sell: 0 |
Cardio Diagnostics 财务报表
Annual | 2023 |
营收: | $17 065.00 |
毛利润: | $-94 555.00 (-554.09 %) |
EPS: | $-0.660 |
FY | 2023 |
营收: | $17 065.00 |
毛利润: | $-94 555.00 (-554.09 %) |
EPS: | $-0.660 |
FY | 2022 |
营收: | $950.00 |
毛利润: | $-15 050.00 (-1 584.21 %) |
EPS: | $-1.510 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Cardio Diagnostics
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。